February 1, 2023
FDA: Class I recall of Medtronic Mahurkar Acute Dual Lumen High Flow Hemodialysis Catheters
Editor's Note
The Food and Drug Administration (FDA) on January 30 identified the recall by Medtronic of its Mahurkar Acute Dual Lumen High Flow (13.5 French) Hemodialysis Catheters (Mahurkar QPlus) as Class I, the most serious.
The recall was initiated because of a potential catheter hub defect that may cause leaks across the catheter’s tubes.
There have been reports of two injuries and no deaths related to this issue.
Distribution dates were March 19, 2022, to September 2, 2022.
Free Daily News
- AI-driven tech partnerships aim to enhance surgical planning, imaging
- Study: Stronger sense of mission reduces burnout, turnover risk among perioperative nurses
- AI agents sweep healthcare, promising speed and efficiency
- Novel liver transplant technique offers new hope for colorectal cancer patients
- Bipartisan bill would expand presidential trade authority over medical goods
- Legislation proposes granting CRNA practice authority to expand anesthesia access for veterans
- FDA announces Class 1 recall for implantable ports
- FDA designates Class 1 recall for embolization devices
- AI reshapes healthcare leadership
- The Joint Commission launches UNIFY 2025 to advance patient safety, healthcare quality
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement